meclofenamic acid has been researched along with flufenamic acid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (33.33) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, DK; Craik, DJ; Iskander, MN; Kolliniatis, E; Munro, SL; Scholz, GH; Stockigt, JR; Topliss, DJ | 1 |
| Arnold, AA; Arnold, LA; Bateman, R; Baxter, JD; Estébanez-Perpiñá, E; Fletterick, RJ; Guy, RK; Mar, E; Nguyen, P; Pallai, P; Rodrigues, ED; Shokat, KM; Webb, P | 1 |
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Atwell, GJ; Brooke, DG; Denny, WA; Flanagan, JU; Hamilton, EJ; Heinrich, D; Jamieson, SM; Owen, PJ; Raynham, T; Rigoreau, LJ; Samlal, SS; Schroeder, E; Silva, S; Soudy, C; Trivier, E; Turnbull, AP | 1 |
| Denny, WA; Flanagan, JU; Heinrich, DM; Jamieson, SM; Raynham, T; Rigoreau, LJ; Silva, S; Trivier, E; Turnbull, AP | 1 |
| Alexandrov, K; Capon, RJ; Cooper, MA; Fontaine, F; Francois, M; Gambin, Y; Jauch, R; Koopman, P; Lua, L; Mamidyala, S; Moustaqil, M; Narasimhan, K; Overman, J; Prokoph, N; Robertson, AAB; Salim, A; Sierecki, E; Zuegg, J | 1 |
| Choi, S; Connelly, S; Johnson, SM; Kelly, JW; Mortenson, DE; Powers, ET; Wilson, IA | 1 |
| Bennett, A; Sanger, GJ | 1 |
| Penning, TM; Smithgall, TE | 1 |
| Brunet, S; Fregnan, GB; Torsello, AL | 1 |
| Hearn, T; Starkweather, S; Wojnar, RJ | 1 |
| Bass, P; Gullikson, GW; Sender, M | 1 |
| Bennett, A; Pratt, D; Sanger, GJ | 1 |
| Eisen, D; Franson, RC; Jesse, R; Lanni, C | 1 |
| Kankaanranta, H; Moilanen, E; Vapaatalo, H | 1 |
| Almli, T; Chen, Q; Lukasiewicz, PD; Olney, JW; Romano, C | 1 |
| Bravo, E; Martínez-Lozano, C; Pérez-Ruiz, T; Sanz, A | 1 |
| De Santi, C; Mosca, F; Pacifici, GM; Pietrabissa, A; Vietri, M | 1 |
| Bohoyo Gil, D; Escandar, GM; Espinosa Mansilla, A; Mora Díez, N; Muñoz de la Peña, A; Olivieri, AC | 1 |
| Chai, MZ; Flanagan, JU; Squire, CJ; Teague, RM; Turnbull, AP; Yosaatmadja, Y | 1 |
| Ikushiro, S; Iwai, Y; Nishikawa, M; Sakaki, T; Sugimoto, H; Takita, T; Yasuda, K; Yasukawa, K; Yogo, Y | 1 |
21 other study(ies) available for meclofenamic acid and flufenamic acid
| Article | Year |
|---|---|
Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Flufenamic Acid; Liver; Liver Neoplasms, Experimental; Meclofenamic Acid; Mefenamic Acid; Molecular Structure; ortho-Aminobenzoates; Rats; Structure-Activity Relationship; Triiodothyronine; Tumor Cells, Cultured | 1993 |
A surface on the androgen receptor that allosterically regulates coactivator binding.
Topics: Allosteric Site; Androgen Receptor Antagonists; Animals; Crystallography, X-Ray; In Vitro Techniques; Mice; Models, Molecular; Nuclear Receptor Coactivator 2; Protein Structure, Tertiary; Receptors, Androgen; Recombinant Proteins | 2007 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Benzoates; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Structure-Activity Relationship | 2012 |
Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Dose-Response Relationship, Drug; Enzyme Inhibitors; HCT116 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Molecular Structure; Pyrrolidinones; Structure-Activity Relationship; Sulfonamides | 2013 |
Small-Molecule Inhibitors of the SOX18 Transcription Factor.
Topics: Animals; Binding Sites; Biological Products; Chlorocebus aethiops; COS Cells; DNA; Drug Design; Genes, Reporter; Immunoglobulin J Recombination Signal Sequence-Binding Protein; Inhibitory Concentration 50; Mice; Nucleic Acid Conformation; Protein Binding; Protein Interaction Maps; Protein Structure, Tertiary; Salicylic Acid; Small Molecule Libraries; SOXF Transcription Factors; Structure-Activity Relationship; Transcriptional Activation | 2017 |
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Topics: Amyloid Neuropathies, Familial; Computer Simulation; Drug Design; Humans; Molecular Docking Simulation; Prealbumin; Protein Multimerization; Protein Stability; Small Molecule Libraries | 2017 |
Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.
Topics: Acetylcholine; Female; Flufenamic Acid; Humans; In Vitro Techniques; Meclofenamic Acid; Mefenamic Acid; ortho-Aminobenzoates; Prostaglandin Endoperoxides, Synthetic; Prostaglandins H; Uterine Contraction | 1979 |
Inhibition of trans-dihydrodiol oxidation by the non-steroidal anti-inflammatory drugs.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Anti-Inflammatory Agents; Aspirin; Benzopyrenes; Dihydroxydihydrobenzopyrenes; Flufenamic Acid; Ibuprofen; Indomethacin; Liver; Male; Meclofenamic Acid; Mefenamic Acid; Oxidoreductases; Rats; Sulindac; Tolmetin | 1986 |
Local anti-inflammatory properties of etoclofene. A new fenamate derivative.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Aspirin; Benzyl Compounds; Carrageenan; Croton Oil; Edema; Ethyl Ethers; Female; Flufenamic Acid; Indazoles; Lethal Dose 50; Male; Meclofenamic Acid; ortho-Aminobenzoates; Phenylbutazone; Rats; Toluene | 1974 |
Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti-inflammatory-analgesic agents.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aurothioglucose; Dust; Female; Flufenamic Acid; Fluorenes; Histamine Release; Humans; Hypersensitivity; Indomethacin; Leukocytes; Magnoliopsida; Male; Meclofenamic Acid; Mefenamic Acid; Middle Aged; ortho-Aminobenzoates; Phenylacetates; Propionates; Tartrazine | 1980 |
Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents; Aspirin; Body Fluids; Cathartics; Cricetinae; Diarrhea; Dinoprostone; Erythrocyte Membrane; Flufenamic Acid; Hemolysis; Indomethacin; Intestinal Mucosa; Intestines; Male; Meclofenamic Acid; Mefenamic Acid; Mesocricetus; Prostaglandin Antagonists; Prostaglandins E | 1982 |
Antagonism by fenamates of prostaglandin action in guinea-pig and human alimentary muscle.
Topics: Animals; Digestive System; Flufenamic Acid; Guinea Pigs; Humans; In Vitro Techniques; Male; Meclofenamic Acid; Mefenamic Acid; Muscle Contraction; Muscle Tonus; ortho-Aminobenzoates; Prostaglandin Antagonists; Prostaglandins | 1980 |
Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents. Modulation by calcium ions.
Topics: Animals; Calcium; Flufenamic Acid; Humans; Indomethacin; Meclofenamic Acid; Neutrophils; ortho-Aminobenzoates; Phospholipases; Phospholipases A; Phospholipases A2; Rabbits | 1980 |
Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Calcium Channel Blockers; Chemotaxis; Flufenamic Acid; Glucuronidase; Humans; In Vitro Techniques; Leukocytes; Meclofenamic Acid; Mefenamic Acid; ortho-Aminobenzoates | 1994 |
Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Chick Embryo; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Flufenamic Acid; Glucose; Kainic Acid; Meclofenamic Acid; Mefenamic Acid; N-Methylaspartate; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; ortho-Aminobenzoates; Oxygen; Patch-Clamp Techniques; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells | 1998 |
Determination of flufenamic, meclofenamic and mefenamic acids by capillary electrophoresis using beta-cyclodextrin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Cyclodextrins; Drug Monitoring; Electrophoresis, Capillary; Flufenamic Acid; Humans; Hydrogen-Ion Concentration; Meclofenamic Acid; Mefenamic Acid; Micelles | 1998 |
Fenamates and the potent inhibition of human liver phenol sulphotransferase.
Topics: Arylsulfotransferase; Dopamine; Enzyme Inhibitors; Flufenamic Acid; Humans; Liver; Meclofenamic Acid; Mefenamic Acid; Molecular Structure; Nitrophenols; ortho-Aminobenzoates | 2000 |
Second-order calibration of excitation-emission matrix fluorescence spectra for the determination of N-phenylanthranilic acid derivatives.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Flufenamic Acid; Meclofenamic Acid; Mefenamic Acid; Multivariate Analysis; Reproducibility of Results; Spectrometry, Fluorescence | 2006 |
Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anti-Inflammatory Agents, Non-Steroidal; Flufenamic Acid; Flurbiprofen; Hydroxyprostaglandin Dehydrogenases; Ibuprofen; Indomethacin; Meclofenamic Acid; Mefenamic Acid; Naproxen; Sulindac; Tolmetin | 2012 |
Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Cytochrome P-450 Enzyme System; Diclofenac; Flufenamic Acid; Humans; Ibuprofen; Meclofenamic Acid; Mefenamic Acid; Streptomyces | 2022 |